share_log

SWS Hemodialysis Care Co., Ltd.'s (SHSE:688410) Largest Shareholder, CEO Guangyong Gao Sees Holdings Value Fall by 8.9% Following Recent Drop

SWS Hemodialysis Care Co., Ltd.'s (SHSE:688410) Largest Shareholder, CEO Guangyong Gao Sees Holdings Value Fall by 8.9% Following Recent Drop

SWS 透析護理有限公司(SHSE:688410)最大股東、首席執行官高廣勇看到其持股價值在最近的下跌後減少了8.9%。
Simply Wall St ·  2024/12/18 08:54

Key Insights

關鍵洞察

  • SWS Hemodialysis Care's significant insider ownership suggests inherent interests in company's expansion
  • 61% of the business is held by the top 3 shareholders
  • 17% of SWS Hemodialysis Care is held by Institutions
  • SWS透析護理的顯著內部股權表明對公司擴張的固有興趣
  • 61%的業務由前三大股東持有
  • 17%的SWS透析護理由機構持有

If you want to know who really controls SWS Hemodialysis Care Co., Ltd. (SHSE:688410), then you'll have to look at the makeup of its share registry. With 49% stake, individual insiders possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果你想知道誰真正控制SWS透析護理有限公司(SHSE:688410),那麼你需要查看其股東登記的構成。個體內部人士持有49%的股份,是公司中股份最多的人。換句話說,這個團體從對公司的投資中獲得的收益(或損失)最大。

And following last week's 8.9% decline in share price, insiders suffered the most losses.

在上週股價下跌8.9%後,內部人士遭受了最大的損失。

Let's take a closer look to see what the different types of shareholders can tell us about SWS Hemodialysis Care.

讓我們更仔細地看看不同類型的股東可以告訴我們關於SWS透析護理的信息。

big
SHSE:688410 Ownership Breakdown December 18th 2024
SHSE:688410 所有權結構 2024年12月18日

What Does The Institutional Ownership Tell Us About SWS Hemodialysis Care?

機構所有權告訴我們關於SWS透析護理什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。

As you can see, institutional investors have a fair amount of stake in SWS Hemodialysis Care. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at SWS Hemodialysis Care's earnings history below. Of course, the future is what really matters.

正如你所看到的,機構投資者在SWS透析護理中擁有相當大的股份。這意味着那些機構的分析師對這隻股票進行了研究,他們認爲這隻股票不錯。但和其他人一樣,他們也可能是錯的。如果多個機構同時改變對某隻股票的看法,您可能會看到股價迅速下跌。因此,看看SWS透析護理的盈利歷史是值得的。當然,未來才是真正重要的。

big
SHSE:688410 Earnings and Revenue Growth December 18th 2024
SHSE:688410 盈利和營業收入增長 2024年12月18日

We note that hedge funds don't have a meaningful investment in SWS Hemodialysis Care. The company's CEO Guangyong Gao is the largest shareholder with 36% of shares outstanding. For context, the second largest shareholder holds about 12% of the shares outstanding, followed by an ownership of 12% by the third-largest shareholder.

我們注意到對SWS 透析護理的對沖基金並沒有實質性的投資。公司的CEO高光勇是最大的 股東,持有36%的流通股份。爲了解釋,第二大股東持有約12%的流通股份,第三大股東的持有比例也是12%。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

爲了讓我們的研究更有趣,我們發現前三大股東在公司中擁有多數股權,意味着他們有足夠的權力影響公司的決策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

雖然研究機構持股可以爲你的研究增值,但研究分析師的推薦也是一種良好的做法,可以深入了解股票的預期表現。儘管有一些分析師的覆蓋,但該公司可能並沒有被廣泛關注。因此,未來可能會獲得更多的關注。

Insider Ownership Of SWS Hemodialysis Care

SWS 透析護理的內部持股情況

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

內部人的定義在不同國家之間可能略有不同,但董事會成員始終被算作內部人。管理層最終向董事會負責。然而,管理者成爲執行董事會成員並不罕見,特別是當他們是創始人或首席執行官時。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部持股是積極的,因爲這表明董事會與其他股東保持良好的一致性。然而,在某些情況下,權力在這個群體中過於集中。

It seems insiders own a significant proportion of SWS Hemodialysis Care Co., Ltd.. Insiders have a CN¥1.8b stake in this CN¥3.8b business. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

據悉,內部人士擁有SWS透析護理有限公司相當大的一部分股份。內部人士在這家價值38億人民幣的業務中擁有18億人民幣的股份。我們認爲這表明與股東的利益是一致的,但值得注意的是,公司仍然相當小;一些內部人士可能是該業務的創始人。您可以點擊這裏查看這些內部人士是否有買入或賣出。

General Public Ownership

公衆持股

The general public-- including retail investors -- own 13% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公衆——包括散戶投資者——在公司中擁有13%的股份,因此不能輕易被忽視。雖然這樣的擁有規模可能不足以影響政策決定,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

With an ownership of 12%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

持有12%的股份,股權投資公司有能力在創造價值的重點上發揮作用,塑造企業策略。有時我們看到股權投資公司會長期存在,但一般來說,他們的投資週期較短,並且如名稱所示,較少投資於公共公司。在一段時間後,他們可能會考慮賣出並將資本重新投入到其他地方。

Private Company Ownership

私有公司所有權

Our data indicates that Private Companies hold 8.6%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據表明,私人公司持有該公司8.6%的股份。私人公司可能是相關方。有時內部人士通過持有私人公司的股份來關注公共公司,而非以個人身份。雖然很難下任何寬泛的結論,但值得注意的是,這是一個進一步研究的領域。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand SWS Hemodialysis Care better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with SWS Hemodialysis Care , and understanding them should be part of your investment process.

思考擁有公司股份的不同群體總是值得的。但爲了更好地理解SWS透析護理,我們需要考慮許多其他因素。例如,投資風險這個始終存在的陰影。我們已經識別出SWS透析護理的3個警告信號,理解這些信號應該成爲你投資過程的一部分。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定這個業務的所有者表現如何的,是未來而不是過去。因此,我們認爲查看這份免費的報告是明智的,報告顯示分析師是否預測了一個更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論